Sg3 Management, LLC Vertex Pharmaceuticals Inc Transaction History

Sg3 Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $103,510 - $120,655	-500 Reduced 10.0%	4,500 $967,000
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $517,525 - $690,224	-2,500 Reduced 33.33%	5,000 $1.18 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $1.92 Million - $2.27 Million	7,500 New	7,500 $2.04 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.